Utility and Safety of Hickman Catheters for Venous Access after Bone Marrow Transplantation

スポンサーリンク

概要

• 論文の詳細を見る
• Japanese Society of Internal Medicineの論文

著者

• Sakamaki Hisashi

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Asaoku Hideki

  Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital

• Tsuzuki Shinobu

  Department Of Transfusion Medicine Nagoya University School Of Medicine

• Sasaki T

  Department Of Psychiatry Tokyo Metropolitan Komagome Hospital

• KUMAGAI Takashi

  First Department of Internal Medicine, Tokyo Medical and Dental University

• SAKAMAKI Hisashi

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• TANIKAWA Syuu

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• AKIYAMA Hideki

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• MAEDA Yoshiharu

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• SASAKI Tsuneo

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• TAKAMOTO Shigeru

  Department of Transfusion Medicine, Aichi Medical College

• TAKAHASHI Keiichi

  Bone Marrow Transplantation Team, Tokyo Metropolitan Komagome Hospital

• ONOZAWA Yasusuke

  Department of Internal Medicine, Tokyo Metropolitan Bokuto Hospital

• Tanikawa Syu

  Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital

• Akiyama Hideki

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Sakamaki H

  Tokyo Metropolitan Komagome Hospital Tokyo Jpn

• Onozawa Yasusuke

  Department Of Internal Medicine Tokyo Metropolitan Bokuto Hospital

• Tanikawa Shu

  Hematopoietic Stem Cell Transplantation Team Tokyo Metropolitan Komagome Hospital

• Maeda Yoshiharu

  Bone Marrow Transplantation Team Tokyo Metropolitan Komagome Hospital

• Tsuzuki Shinobu

  Department Of Molecular Medicine Aichi Cancer Center Research Institute

• Sasaki Tsuneo

  Bone Marrow Transplantation Team Tokyo Metropolitan Komagome Hospital

• Sakamaki Hisashi

  Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital

• Sasaki Tsukasa

  Department Of Psychiatry Tokyo Metropolitan Komagome Hospital

• Onozawa Yasusuke

  Department Of Hematology And Oncology Tokai University School Of Medicine

• Kumagai Takashi

  First Department Of Internal Medicine Tokyo Medical And Dental University

• Takahashi Keiichi

  Bone Marrow Transplantation Team Tokyo Metropolitan Komagome Hospital

関連論文

• Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
• CD56 expression in human myeloma cells derived from the neurogenic gene expression : possible role of the SRY-HMG box gene, SOX4
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
• Primary Sclerosing Cholangitis Complicated with Idiopathic Thrombocytopenic Purpura
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
• Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9
• Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Is Eradication Therapy Useful as the First Line of Treatment in Helicobacter pylori-Positive Idiopathic Thrombocytopenic Purpura? Analysis of 207 Eradicated Chronic ITP Cases in Japan
• Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
• Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
• Utility and Safety of Hickman Catheters for Venous Access after Bone Marrow Transplantation
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
• A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
• Endoscopic Findings of Acute Intestinal Graft-versus-host Disease after Bone Marrow Transplantation
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
• Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
• Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
• Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
• Pneumatosis coli after Thalidomide Treatment
• Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
• Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
• Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
• Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
• Bone marrow transplantation in subjects with mental disorders
• IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
• An Increase in MPC-1^- and MPC-1^-CD45^+ Immature Myeloma Cells in the Progressive States of Bone Marrow Plasmacytosis : The Revised Phenotypic Classification of Monoclonal Marrow Plasmacytosis (MOMP-2005)
• Variation of Oceanic Condition in Hyuga-Nada, Japan
• WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
• Psychological factors and survival after bone marrow transplantation in patients with leukemia
• Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
• Recombinant human erythropoetin (rhEPO) administration to marrow donors
• Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
• Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
• Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
• Distinctive cell properties of B cells carrying the BCL2 translocation and their potential roles in the development of lymphoma of germinal center type
• Erythrocytosis caused by erythropoietin-producing thymic carcinoma
• Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
• Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
• Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
• A12 Molecular variations in SSU rDNA sequences of some species of Ascogregarina, the non-pathogenic parasites of mosquitoes
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
• Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
• 原発性胆汁性肝硬変に全身性エリテマトーデスを合併した2例
• 多発性筋炎を合併した自己免疫性肝炎の1例
• 肝機能異常を伴った多発性骨髄腫の1例
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
• Osteonecrosis of the humeral head
• Clinical Features and Outcomes of 35 Disseminated Intravascular Coagulation Cases Treated with Recombinant Human Soluble Thrombomodulin at a Single Institution
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
• Advances in therapies for acute promyelocytic leukemia
• Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis
• Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
• Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

もっと見る 閉じる

スポンサーリンク